Liuqing Yang Selected Research

picolinic acid (chromium picolinate)

3/2018	Pharmacokinetics and bioavailability of chromium malate and its influence on trace metals absorption after oral or intravenous administration.
11/2015	Evaluation of the Reproductive Toxicity, Glycometabolism, Glycometabolism-Related Enzyme Levels and Lipid Metabolism of Chromium Malate Supplementation in Sprague-Dawley Rats.
11/2015	Evaluation of 90-day Repeated Dose Oral Toxicity, Glycometabolism, Learning and Memory Ability, and Related Enzyme of Chromium Malate Supplementation in Sprague-Dawley Rats.
7/2015	Effects of chromium malate on glycometabolism, glycometabolism-related enzyme levels and lipid metabolism in type 2 diabetic rats: A dose-response and curative effects study.
1/2015	Type 2 diabetic rats on diet supplemented with chromium malate show improved glycometabolism, glycometabolism-related enzyme levels and lipid metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liuqing Yang Research Topics

Disease

46	Neoplasms (Cancer) 04/2022 - 02/2004
11	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2014
10	Insulin Resistance 03/2021 - 01/2015
7	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2014
5	Type 2 Diabetes Mellitus (MODY) 03/2021 - 11/2016
4	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 08/2013
4	Body Weight (Weight, Body) 11/2019 - 12/2011
3	Pain (Aches) 01/2022 - 01/2021
3	COVID-19 01/2022 - 01/2021
3	Triple Negative Breast Neoplasms 01/2022 - 02/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
3	Adenocarcinoma 03/2021 - 10/2019
3	Constipation 01/2021 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 10/2016
3	Hypoxia (Hypoxemia) 01/2021 - 01/2018
3	Necrosis 03/2020 - 08/2015
3	Carcinoma (Carcinomatosis) 07/2018 - 06/2012
3	Sarcoma (Soft Tissue Sarcoma) 12/2014 - 01/2012
3	Genetic Translocation (Chromosomal Translocation) 07/2014 - 01/2012
2	Infections 04/2022 - 01/2018
2	Carcinogenesis 04/2022 - 10/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 07/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2021
2	Muscular Dystrophies (Muscular Dystrophy) 01/2021 - 11/2020
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 03/2020
2	Inflammation (Inflammations) 03/2020 - 05/2017
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2020
2	Ischemia 01/2020 - 10/2017
2	Heart Failure 01/2020 - 04/2016
2	Melanoma (Melanoma, Malignant) 01/2020 - 02/2016
2	Lung Neoplasms (Lung Cancer) 01/2020 - 07/2010
2	Memory Disorders (Memory Loss) 01/2019 - 12/2015
2	Lymphopenia (Lymphocytopenia) 01/2019 - 01/2019
2	Glioma (Gliomas) 11/2018 - 08/2017
2	Brain Neoplasms (Brain Tumor) 12/2017 - 08/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2017 - 07/2010

Drug/Important Bio-Agent (IBA)

18	Long Noncoding RNAIBA 01/2022 - 07/2014
17	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2018
9	ChromiumIBA 01/2020 - 07/2015
8	Peptides (Polypeptides)IBA 01/2021 - 01/2010
8	malic acid (malate)IBA 01/2019 - 07/2015
7	MicroRNAs (MicroRNA)IBA 01/2022 - 02/2004
7	Pharmaceutical PreparationsIBA 08/2020 - 06/2012
7	Insulin (Novolin)FDA Link 11/2019 - 01/2015
7	Blood Glucose (Blood Sugar)IBA 12/2018 - 12/2011
6	Biological ProductsIBA 04/2022 - 12/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2017
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
6	LigandsIBA 11/2016 - 06/2005
5	picolinic acid (chromium picolinate)IBA 03/2018 - 01/2015
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2022 - 06/2013
4	VaccinesIBA 01/2022 - 01/2021
4	Diethylhexyl Phthalate (DEHP)IBA 03/2021 - 01/2019
4	LipidsIBA 01/2021 - 01/2017
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
4	C-PeptideIBA 11/2015 - 01/2015
3	C-Reactive ProteinIBA 05/2022 - 01/2019
3	CytokinesIBA 05/2021 - 02/2018
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2021 - 01/2019
3	phthalic acid (phthalate)IBA 03/2021 - 01/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 06/2012
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
3	EnzymesIBA 01/2021 - 01/2010
3	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2018
3	Androgen Receptors (Androgen Receptor)IBA 11/2019 - 08/2013
3	Alanine Transaminase (SGPT)IBA 01/2019 - 06/2013
3	Liposomes (Liposome)IBA 10/2018 - 11/2016
3	chromic chloride FDA Link 03/2018 - 01/2015
3	HDL CholesterolIBA 02/2018 - 11/2015
3	LDL CholesterolIBA 02/2018 - 11/2015
3	CholesterolIBA 02/2018 - 11/2015
3	Triglycerides (Triacylglycerol)IBA 02/2018 - 11/2015
3	Liver GlycogenIBA 11/2015 - 12/2011
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2021
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 01/2021
2	PlasticizersIBA 03/2021 - 11/2019
2	(1-6)-alpha-glucomannan (glucomannan)IBA 01/2021 - 01/2021
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2021
2	DystrophinIBA 01/2021 - 11/2020
2	Hormones (Hormone)IBA 01/2021 - 08/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2020
2	Gemcitabine FDA Link 01/2021 - 04/2020
2	IronIBA 01/2021 - 03/2020
2	AntigensIBA 08/2020 - 01/2019
2	Carrier Proteins (Binding Protein)IBA 08/2020 - 01/2020
2	Coloring Agents (Dyes)IBA 01/2020 - 11/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 06/2012
2	Nucleic AcidsIBA 01/2019 - 11/2014
2	TensinsIBA 01/2019 - 01/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 01/2015
2	Hyaluronic Acid (Hyaluronan)IBA 11/2018 - 06/2013
2	Melanins (Melanin)IBA 06/2018 - 05/2017
2	Fluorouracil (Carac)FDA LinkGeneric 02/2018 - 06/2013
2	EBI-907IBA 02/2016 - 01/2016

Therapy/Procedure

18	Therapeutics 01/2022 - 05/2013
5	Drug Therapy (Chemotherapy) 01/2021 - 11/2016
2	Radiotherapy 01/2021 - 01/2020
2	Immunotherapy 11/2020 - 01/2019
2	Oral Administration 05/2017 - 01/2014